Neurological Disorder Diagnostics Market is valued around USD 6.81 Billion in 2021 and expected to reach USD 10.73 Billion by 2028 with the CAGR of 6.71% over the forecast period. Increased prevalence of neurological disorders and increase in technological advancements are the key drivers for Global Neurological Disorder Diagnostics Market.
Neurological disorder diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about neurological disorder diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with disorder type, technology type, end user.
Neurological disorder diagnostics are the various medical devices used for the diagnosis of various neurological disorders such as Parkinson’s disease, Alzheimer’s disease and others. These medical devices include various imaging devices such as CT Scan, Magnetic resonance Imaging, biopsy and others. Increasing prevalence of these disorders has led to the increased demand for better diagnostics and better treatment over the period of time.
There are various factors driving the growth of the neurological disorder diagnostics market, one of the major factors expected to drive the growth of this market is increase in the prevalence of neurological disorders and others coupled with increased awareness among people over the period of time. As per Alzheimer’s Association 2018 report, there were around 5.7million of Americans living with Alzheimer’s dementia in 2018 which includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s. Furthermore, various collaborations among major market players are also expected to promote the growth of neurological disorder diagnostics over the forecast period. Moreover, increase in various technological advancements for the development of novel diagnostics are anticipated to fuel drive the growth of market. However, high costs of these medical devices are expected to hinder the growth of neurological disorder diagnostics market.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 6.81 Billion|
|Base year considered||2021|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 10.73 Billion|
|Tables, Charts & Figures:||175|
|Key Players/Companies||Koninklijke Philips N.V., Masimo Corporation, York Instruments Ltd., Esaote SpA, General Electric Company, Canon Medical Systems Corporation., Siemens Healthineers, Natus Medical Inc., Nihon Kohden Corporation, Compumedics Ltd, Advanced Brain Monitoring, and others.|
|Segments Covered||By Disorder Type, By Technology Type, By End-User|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
By Disorder Type
By Technology Type
By Disorder Type
By Technology Type
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®